glp 1 and sexual dysfunction MTP 115: GLP-1 Libido: The Hidden Side Effects of Weight Loss Drugs The Impact of Glucagon-like Peptide-1

doi:10.1038/s41467-021-24607-6 74

Beta-blockers, monoamine oxidase inhibitors (MAOIs), androgens, quinolones, salicylates, selective serotonin reuptake inhibitors (SSRIs), and other antidiabetic medications all have the potential to further lower blood sugar and should be avoided by anyone taking semaglutide for weight loss or to treat type 2 diabetes

Data extraction and quality assessment A single reviewer (DM) undertook data extraction and quality assessment

Patients with diabetes face additional risk, as dehydration can precipitate diabetic ketoacidosis in susceptible individuals

Postprandial plasma glucose concentrations are regulated by gut incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which augment insulin secretion when glucose is administered orally

Latest Research on Semaglutide and Post-Surgical Patients The field of GLP-1 receptor agonists is growing fast